UNSPSC 51453103: Morantel citrate

This classification denotes an antihelminthic agent with the molecular formula C12H16N2S.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VC8Z4SS5QX, chemically known as pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-((1e)-2-(3-methyl-2-thienyl)ethenyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1), but more generally known as morantel citrate, which bears US NIH Compound Identifier 5702276.

European Medicines Agency schedules morantel citrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09063MIG. Most nations, for tariff purposes, schedule morantel citrate under HS 29349990. SMILES: CC1CCSC1/C=C/C2=NCCCN2C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.

UNSPSC 51453103 Morantel citrate is a Commodity code that classifies a specific antiparasitic pharmaceutical active ingredient, but recent state and local procurement activity under this code shows little relevance to the nominal product. The two most recent opportunities posted under this code involve pharmaceutical procurement, but neither addresses morantel citrate directly. Instead, the Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets, while Seminole County, Florida solicited Naloxone and Safe Drug Deactivation Systems. The code appears to be a misclassification catch-all or system artifact within state and local procurement databases rather than a category under which active pharmaceutical purchasing occurs. State and local health departments, county health agencies, and community health systems are the issuing bodies visible in recent postings, but the disconnect between the code's nominal scope and the actual commodities being bought suggests limited utility for vendors specializing in morantel citrate or related antiparasitic formulations.

Geographic activity is concentrated in Illinois and Florida based on recent records, with no additional jurisdictions represented in the sample. The Illinois Department of Public Health contract, posted August 28, 2026 with a completed award to Chartwell Rx LLC, supplied antibiotic pharmaceuticals through a cooperative purchasing vehicle rather than a direct RFP, while the Seminole County IFB for Naloxone (posted June 30, 2026, with a response deadline of July 26, 2026) reflects opioid-reversal and drug-management procurement unrelated to antiparasitic therapeutics. Vendors should verify whether opportunities tagged with this code represent genuine morantel citrate demand or reflect cataloging inconsistencies before investing in pursuit.